The maintenance of patients with renal transplant typically involves two or more drugs to
prevent rejection and prolong graft survival. The calcineurin inhibitors (CNI) are the most …

Background Debate is increasing on whether mycophenolic acid (MPA) provides survival
benefits comparable to azathioprine (AZA) after renal transplantation. Methods This …

Introduction: Over the past decades, calcineurin inhibitors (CNIs) have become the
cornerstone of transplant immunosuppression. CNIs can exert negative effects on chronic …

Objectives Simultaneous transplantation of a solid organ and bone marrow from the same
donor is a possible means of achieving transplant tolerance. Here, we attempted to identify …

Background Solid organ transplant recipients are at increased risk of developing
malignancies. The objective of this prospective, observational, one-armed study was to …

Long‑term outcome of renal transplantation: a 10‑year follow‑up of 765 recipients Page 1
POLISH ARCHIVES OF INTERNAL MEDICINE 2019; 129 (7-8) 476 ORIGINAL ARTICLE …

Background Few studies have evaluated the effect of different immunosuppressive
strategies on long-term kidney transplant outcomes. Moreover, as they were usually based …

While belatacept has shown favorable short‐and midterm results in kidney transplant
recipients, only projections exist regarding its potential impact on long‐term outcome …

A cohort of recipients of renal transplant after 2000 (N= 310) was prospectively screened on
the day of transplantation and 1 month later for a panel of 11 thrombophilic factors to assess …

Background: The influence of the conversion from cyclosporine (CsA) to everolimus (EVR)
on the chronopharmacokinetics of mycophenolic acid (MPA) and its glucuronide (MPAG) …